Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sudden Infant Death | 2 | 2019 | 6 | 0.730 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2012 | 12 | 0.690 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 162 | 0.690 |
Why?
|
| Nerve Net | 1 | 2019 | 76 | 0.670 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 103 | 0.660 |
Why?
|
| Child Development | 1 | 2019 | 88 | 0.650 |
Why?
|
| Homeostasis | 1 | 2019 | 188 | 0.630 |
Why?
|
| Chemoreceptor Cells | 4 | 2006 | 20 | 0.590 |
Why?
|
| Endocannabinoids | 1 | 2016 | 39 | 0.550 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 85 | 0.510 |
Why?
|
| Inflammation | 1 | 2019 | 618 | 0.500 |
Why?
|
| Cannabis | 1 | 2016 | 79 | 0.490 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 197 | 0.370 |
Why?
|
| Models, Animal | 1 | 2011 | 134 | 0.370 |
Why?
|
| Arteries | 3 | 2006 | 65 | 0.360 |
Why?
|
| Infant, Newborn | 4 | 2019 | 894 | 0.290 |
Why?
|
| Rats | 6 | 2006 | 3483 | 0.280 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2006 | 4 | 0.270 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2006 | 4 | 0.270 |
Why?
|
| Carotid Body | 5 | 2006 | 7 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 286 | 0.270 |
Why?
|
| Narcotics | 1 | 2006 | 32 | 0.270 |
Why?
|
| Ganglia, Sensory | 1 | 2004 | 4 | 0.250 |
Why?
|
| Central Nervous System | 1 | 2006 | 135 | 0.250 |
Why?
|
| Receptors, Cannabinoid | 1 | 2004 | 26 | 0.250 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 730 | 0.220 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2002 | 4 | 0.220 |
Why?
|
| Pregnancy | 4 | 2016 | 1549 | 0.220 |
Why?
|
| Receptors, Nicotinic | 1 | 2002 | 106 | 0.200 |
Why?
|
| Lead | 1 | 2002 | 93 | 0.200 |
Why?
|
| Nodose Ganglion | 3 | 2006 | 4 | 0.190 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 1371 | 0.180 |
Why?
|
| Animals, Newborn | 4 | 2005 | 343 | 0.130 |
Why?
|
| Neurons | 1 | 2002 | 1175 | 0.130 |
Why?
|
| Brain | 1 | 2002 | 1346 | 0.120 |
Why?
|
| Mice | 1 | 2006 | 5913 | 0.120 |
Why?
|
| Animals | 7 | 2011 | 15081 | 0.120 |
Why?
|
| Humans | 6 | 2019 | 37093 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2006 | 1618 | 0.110 |
Why?
|
| Methadone | 1 | 2012 | 19 | 0.110 |
Why?
|
| Buprenorphine | 1 | 2012 | 21 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2012 | 95 | 0.100 |
Why?
|
| Female | 4 | 2016 | 20969 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2006 | 1207 | 0.070 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 56 | 0.070 |
Why?
|
| Age Factors | 2 | 2006 | 1033 | 0.070 |
Why?
|
| Neurons, Afferent | 1 | 2005 | 43 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 137 | 0.060 |
Why?
|
| Apnea | 1 | 2004 | 6 | 0.060 |
Why?
|
| Superior Cervical Ganglion | 1 | 2004 | 5 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2004 | 207 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2004 | 73 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 64 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 893 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 95 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 35 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2002 | 66 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 111 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2002 | 89 | 0.050 |
Why?
|
| Pyridines | 1 | 2002 | 116 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2002 | 216 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1039 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2005 | 78 | 0.030 |
Why?
|
| Rhodamines | 1 | 2005 | 21 | 0.020 |
Why?
|
| Dextrans | 1 | 2005 | 21 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2004 | 10 | 0.020 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2004 | 34 | 0.010 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2004 | 6 | 0.010 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2004 | 48 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 550 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2004 | 129 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 42 | 0.010 |
Why?
|
| Male | 1 | 2002 | 20025 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 207 | 0.010 |
Why?
|
| Dopamine | 1 | 2004 | 245 | 0.010 |
Why?
|
| Nicotine | 1 | 2004 | 257 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 922 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 674 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3562 | 0.010 |
Why?
|